Equity Overview
Price & Market Data
Price: $18.16
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $2,996,892,416
Daily Volume: 0
Performance Metrics
1 Week: 6.26%
1 Month: 22.21%
3 Months: -0.38%
6 Months: 39.05%
1 Year: 142.5%
YTD: -7.16%
Company Details
Employees: 258
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.